Is Post-Transplant Cyclophosphamide the New Methotrexate?

Is Post-Transplant Cyclophosphamide the New Methotrexate?

Introducing post-transplant, cyclophosphamide (PT-Cy) graft-versus-host disease (GVHD) prophylaxis in the setting of haploidentical donor transplantation has marked the most important advance in allogeneic hematopoietic cell transplantation (alloHCT) within the past 15 years. The efficacy of this pr...

Full description

Bibliographic Details
Main Authors: Alberto Mussetti, Annalisa Paviglianiti, Rocio Parody, Anna Sureda
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
allogeneic transplantation
GVHD
post-transplant cyclophosphamide
HLA-identical
haploidentical
Online Access:https://www.mdpi.com/2077-0383/10/16/3548

Internet

https://www.mdpi.com/2077-0383/10/16/3548

Similar Items